ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ANIP ANI Pharmaceuticals Inc

67.11
0.59 (0.89%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 126,678
Bid Price 64.38
Ask Price 71.95
News -
Day High 67.87

Low
37.62

52 Week Range

High
70.81

Day Low 66.78
Company Name Stock Ticker Symbol Market Type
ANI Pharmaceuticals Inc ANIP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.59 0.89% 67.11 17:30:00
Open Price Low Price High Price Close Price Prev Close
66.85 66.78 67.87 67.11 66.52
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,577 126,678 $ 67.33 $ 8,529,627 - 37.62 - 70.81
Last Trade Time Type Quantity Stock Price Currency
16:02:10 49 $ 67.11 USD

ANI Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.41B 21.08M - 486.82M 17.15M 0.81 82.39
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ANI Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ANIP Message Board. Create One! See More Posts on ANIP Message Board See More Message Board Posts

Historical ANIP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week64.6367.8764.2965.7892,7372.483.84%
1 Month67.6868.4064.2066.37124,163-0.57-0.84%
3 Months55.9970.8154.6265.88149,38611.1219.86%
6 Months62.0670.8148.1459.28154,6245.058.14%
1 Year37.8670.8137.6257.55152,21329.2577.26%
3 Years33.5370.8122.3146.60117,84633.58100.15%
5 Years69.5586.9622.3148.74113,674-2.44-3.51%

ANI Pharmaceuticals Description

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Your Recent History

Delayed Upgrade Clock